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ABSTRACT 
Fungi of the genus Penicillium are promising sources of bioactive substances. 
Fungal strains isolated from poorly characterized habitats are currently under active 
investigation as potential producers of biologically active compounds. Penicillium 
nordicum is mostly known by its ability to produce the mycotoxin ochratoxin A in 
several protein- and salt-rich food matrices like processed meat and cheese, but it can 
also produce an array of other secondary metabolites. In a previous study, strains of this 
species were found to produce, under specific growth conditions, one unidentified 
compound in apparently big amounts, without producing ochratoxin A.  
The aim of the present study was to evaluate the bioactive properties of this 
compound in terms of antioxidant, antimicrobial, cytotoxic and phytotoxic properties. 
For that purpose, the fungus was grown on chorizo-based medium and the aqueous 
extract of the compound was used for further tests.  
Pestalotin was the predominant compound in the fungal extract, with 
questiomycin and 7-hydroxypestalotin also being found at lower concentrations, as 
detected by Liquid Chromatography-Mass Spectrometry (HPLC-MS/MS) based multi-
metabolite method.  
The extract did not show any cytotoxic activity in non-tumor porcine liver 
primary culture cells and human tumor cell lines. The antibacterial effect on human 
clinical isolates and antifungal effect on foodborne and environmental isolates was also 
not significant. However, it showed significant effects on seed germination as well as on 
root and shoot growth of tomato, lettuce, wheat and oat. The root growth inhibition 
ranged from 65.9% to 100%, and the shoot growth was reduced in 22.7% to 92%, being 
tomato the most sensitive plant.  
The extract can be considered as a potential bioherbicide by its phytotoxic effect, 
without noticeable negative effects on human and animal cells and also on the 
environment. Further tests on herbicidal potential are now under development.  
 
Keywords: Penicillium nordicum, cytotoxicity, antioxidant, antimicrobial, bioherbicide   
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RESUMO 
Espécies fúngicas do género Penicillium são fontes promissoras de substâncias 
bioativas. Estirpes isoladas de habitats pouco caracterizados são atualmente sujeitos a 
forte investigação como potenciais fontes destas substâncias.  
Penicillium nordicum é uma espécie reconhecida pela sua capacidade para 
produzir a micotoxina ocratoxina A em matrizes alimentares ricas em proteína e sal. No 
entanto, é também produtora de uma alargada gama de outros metabolitos secundários. 
Num estudo prévio, foi identificada em estirpes desta espécie a capacidade de, sob 
determinadas condições de incubação, produzir um composto desconhecido em 
quantidades aparentemente elevadas, sem produzir ocratoxina A.  
O objetivo do presente estudo foi avaliar as propriedades bioativas deste 
composto, nomeadamente propriedades antioxidantes, antimicrobianas, citotóxicas e 
fitotóxicas. Para o efeito, o fungo foi produzido em meio de cultura à base de chouriço e 
o extrato aquoso foi usado para os testes necessários.  
Após análise multi-metabolito por Cromatografia Líquida – Espetrometria de 
Massa (HPLC-MS/MS), pestalotina foi o composto encontrado no extrato em maior 
quantidade, sendo os compostos questiomicina e 7-hidroxipestalotina encontrados em 
menores concentrações.  
O extrato não mostrou atividade citotóxica em cultura células primárias de fígado 
de porco não-tumorais ou em linhas celulares humanas tumorais. O efeito antibacteriano 
em isolados clínicos humanos e antifúngico em isolados de origem alimentar e 
ambiental não foi significativo. No entanto, foi detetado efeito fitotóxico significativo 
ao nível da germinação de sementes e do crescimento de raízes e rebentos de tomate, 
alface, trigo e aveia. A inibição do crescimento radicular variou entre 65.9% e 100%, e 
o crescimento do rebento foi inibido em 22.7% a 92%. O tomate foi a espécie mais 
sensível ao extrato.  
Pelo efeito fitotóxico observado neste estudo, o extrato pode ser considerado um 
potencial bioherbicida, sem efeitos negativos significativos para células animais e para o 
ambiente. O potencial bioherbicida do extrato continua em estudo. 
 
Palavras-passe: Penicillium nordicum, citotoxicidade, antioxidante, antimicrobiano, 
bioherbicida   
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I. INTRODUCTION 
I.1. Framework 
Fungi of the genus Penicillium are promising sources of bioactive substances. Fungal 
strains isolated from poorly characterized or completely uncharacterized habitats are currently 
under active investigation as potential producers of biologically active compounds. These 
habitats include ecological niches in which microorganisms are continuously exposed to 
stressful influences (Kozlovskii et al., 2015). 
Exometabolites produced by different types of microorganisms may find multiple 
applications in different fields of industry. Currently, the pharmaceutical industry is regarded 
as the major application field for products from fungi. Many of fungal metabolites have 
entered the clinical pipeline in view of being exploited as novel drugs (Nicoletti & Trincone, 
2016). 
Penicillium nordicum is a mycotoxinogenic fungus, usually contaminating protein rich 
food with high levels of NaCl, which is capable of producing big number of exometabolites, 
known also as secondary metabolites (Rodríguez et al., 2014). During testing secondary 
metabolites produced by Penicillium nordicum strains it was discovered that, under certain 
growth conditions, and concomitantly with the production of the well-known metabolite 
ochratoxin A (OTA), the fungus was also producing one unidentified compound in apparently 
big amounts. This compound was considered a good candidate for further tests for bioactivity 
in terms of potential industrial applications. 
To avoid the simultaneous production of other exometabolites with the compound of 
interest, it is essential to adjust the environmental conditions of compound production. After a 
virtually pure extract of the compound is obtained further tests can then be performed. 
However, since P. nordicum is a well-known mycotoxin-producing fungus, toxicity tests need 
to be done for the extract. Cytotoxicity tests are very important to be performed for new 
compounds in terms of determining their possible influence on other cells, either human or 
animal. 
In terms of food or pharmaceutical industry applications of new, unknown compounds, 
some tests are also interesting in order to determine their potential antioxidant, anti-
inflammatory, antifungal and antimicrobial activity. Some compounds produced by 
microorganism can also find applications in agriculture as herbicides or insecticides.  
 
  2 
I.2. Objectives 
The general aim of this project was to identify a secondary metabolite produced by 
P. nordicum and characterize it in terms of bioactivity.  
To achieve this purpose, several tests were performed: 
1. Optimization of the production process; 
2. Elucidation of the extract composition by LC-MS (Liquid Chromatography-Mass 
Spectrometry); 
3. Evaluation of the bioactive properties of the extract: cytotoxicity (with tumor and 
non-tumor cells), antimicrobial (against bacteria and fungi), antioxidant (DPPH free radicals 
scavenging activity, reducing power, inhibition of β-carotene bleaching and lipid peroxidation 
inhibition) and phytotoxicity (effect on seed germination and plantlet growth).  
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II. LITERATURE REVIEW 
II.1. Penicillium nordicum and production of secondary metabolites 
Species from the genus Penicillium are the second biggest producers of secondary 
metabolites (first is Aspergillus), with around 3.8 metabolites per species. Secondary 
metabolites (exometabolites) are small molecules produced during morphological and 
chemical differentiation that are outward directed. Unlike primary metabolites 
(endometabolites), that are fluctuating in concentration (the fluxome) or are transformed into 
other endometabolites, secondary metabolites are usually located in or on the cell wall and 
accumulated. Endometabolites are typical for almost all species of fungi (and most other 
kinds of organisms) but exometabolites are specific of certain species. Their most important 
feature is that environmental factors like light, pH, redox potential, temperature, water activity 
and also exometabolites from other species play a regulatory effect on regulatory proteins for 
exometabolite expression in the fungus (Frisvad, 2015).  
Secondary metabolites are often regarded as biochemical markers for the classification 
of some species of fungi, and can provide useful information for the ascription of isolates 
displaying controversial morphological features. Also, the biologically active metabolites of 
Penicillium may have useful properties that can be exploited for developing new 
pharmaceuticals (Nicoletti et al., 2007; Nicoletti and Trincone, 2016). 
Penicillium nordicum is one of mycotoxinogenic species from the genus Penicillium 
which is usually contaminating protein-rich food with high levels of NaCl. It is usually found 
on dry-cured meat products like: cured ham, salami, but also on salted fish and, occasionally, 
on cheese and jam (Ferrara et al., 2016). P. nordicum is capable of producing big number of 
secondary metabolites.  
The exometabolites produced by P. nordicum with their bioactivity already known are 
presented in Table II.1. 
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Table II.1. Exometabolites produced by Penicillium nordicum and their bioactivity (Frisvad et al., 
2004; Rodríguez et al., 2014)  
Extrolite biosynthetic family Activity 
Verrucolones Herbicidal 
Pestalotins Herbicidal 
Ochratoxin A (OTA) Mycotoxin (Nephrotoxic, 
Hepatotoxic, Immunotoxic) 
Sclerotigenin Antiinsectan 
Viridic acid Mycotoxin 
 
Some of these metabolites are toxic to animals in low amounts, and are known as 
mycotoxins. The best known mycotoxin produced by P. nordicum is ochratoxin A (OTA), 
which can be detected in both mycelium and spores, as well as in contaminated food products. 
OTA is a potent mycotoxin, with nephrotoxic, nephrocarcinogenic, teratogenic, neurotoxic 
and immunotoxic activities. It is also involved in porcine and chicken nephropathy and it is 
suspected to be an important etiological factor in human Balkan endemic nephropathy, as in 
the occurrence of tumors of urogenital tract (Ferrara et al., 2016). It has been classified into 
Group 2B (possible human carcinogen) by the International Agency for Research of Cancer 
(IARC, 1993) and the Commission of European Communities fixed maximum admissible 
levels in several foodstuffs (EC, 2006, 2010).  
The production of OTA by P. nordicum, like other toxins for different species of fungi, 
is dependent on growth substrates and environmental conditions (Vipotnik et al., 2017).  
 
II.2. Optimization of compounds production processes  
By definition, the production of secondary metabolites in fungi is dependent on growth 
substrates and environmental conditions. Fungal species are specifically associated to certain 
habitats, plants, animals or other organisms. There they produce exometabolites in response to 
the challenges in the particular habitat. Light, pH, redox potential, temperature, water activity, 
carbon sources, nitrogen sources, iron starvation, and exometabolites from other species can 
all have an effect on the regulatory proteins for exometabolites expression in a fungus, usually 
by stimulating the expression of gene clusters that would otherwise be silent (Frisvad, 2015).  
The manipulation of the environment and nutrition of the microorganisms had shown 
substantial impacts on the quantity and diversity of secondary metabolite production. The 
optimization of the microbial culture may have great effects on the results of natural products 
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screening program. For the full metabolomic diversity exploitation of one or few 
microorganisms, the methodical modification culture growing conditions (OSMAC : one 
strain; many metabolites) approach is commonly used. However for a large-scale screening 
program it becomes problematic because application a suite of culture conditions for even one 
factor (media, pH, temperature, etc.) to every screened organism becomes hard and 
impractical (VanderMolen et al., 2013).  
In a study presented by Medina et al. (2015) it was proven that different salt 
concentrations in the culture medium influenced the growth of P. nordicum and A. ochraceus 
and their exometabolites production (in this case OTA). It was shown that in high salt 
concentrations, where water activity was relatively low, the growth of P. nordicum and OTA 
production were better than on media with low salt concentrations with high water activity. 
For other fungal species those growth conditions represent environmentally stressed 
conditions and give the fungi from genera Penicillium and Aspergillus an ecological 
advantage to colonize those types of environments.  
Another study proving that environmental conditions influence secondary metabolites 
production by fungi was presented by Kozlovskii et al. (2016). In this study Penicillium 
strains grown under different conditions (acidic, neutral and alkaline) shown to produce 
metabolites of different structural types.   
For industrial applications of newly discovered bioactive compounds it is essential to 
optimize the production of a target bioactive compound at an industrial scale. As the addition 
to laboratory tests of different incubation conditions for microorganisms the discipline of 
metabolic engineering has increasingly been applied to the secondary metabolite studies to 
boost commercial production of target molecules. The main objective of this is to 
overproduce chemicals that are valuable to mankind from microbial or mammalian cells. It 
attempts to systematically understand and engineer a cell's metabolic network at a systems 
level. Systems metabolic engineering has been already applied to platform production strains 
such as Escherichia coli and Saccharomyces cerevisiae for the production of various 
chemicals, biofuels and biopolymers (Kim et al., 2016).  
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II.3. Structural elucidation of chemical compounds  
Introduction of spectrometric tests in the new natural products discovery allows 
structural information to be used to identify and filter out any known compounds that are 
present in an extract. This way of natural products discovery is called ‘structure-based’ 
method. Thanks to this method it is possible to elucidate the structure of the chemical 
compounds and submit this information to databases that relate structure with bioactivity. By 
using this method, some of the identified compounds will be associated with confirmed 
bioactivity but it is also possible to identify compounds for which no bioactivity can be found 
(Henke & Kelleher, 2016).  
Methods frequently used are structure-based methods. First of all, extracts from 
microbial or plant sources are screened for bioactivity and only if an extract displays activity, 
it is fractionated and the resulting fractions are then rescreened for that same activity. Later 
the compound is purified and then nuclear magnetic resonance spectroscopy (NMR) or high-
resolution mass spectrometry (HRMS) are performed (Henke & Kelleher, 2016).  
Together witch bioactivity tests as the base for a primary screen, the spectrometric or 
spectroscopic data has recently emerged as a viable option to screen for new natural products  
and they are used to determine already known compounds. The most common methods of 
detection for early stages are: ultraviolet-visible spectroscopy (UV/Vis) that provides 
information on chromophores present in a compound; NMR that provides information on 
chemical environment and connectivity within a molecule through NMR-active isotopes (e.g., 
1H, 13C, 15N); mass spectrometry (MS) that provides the mass of compounds and, if the 
instrument is capable of fragmentation, the masses of subsequent fragment ions. Very often 
those techniques are coupled to obtain more information about the compound. The most 
efficient method is MS or tandem MS because often only nanograms of material are needed to 
perform the test (Henke & Kelleher, 2016).  
Recently, LC-MS technique is frequently used in terms of natural extracts composition 
analysis and trace - level determination of food contaminants. Combination of MS with LC 
(liquid chromatography) is considered as the best technique for quantification and 
semi quantitative screening of natural products. Although, GC (gas chromatography) in 
combination with MS is still frequently used in analyses of volatile, non- polar small 
molecules, LC-MS allows to perform more sensitive and selective determination of other 
more polar or ionic molecules. The goal of the use of LC-MS in initial screening is to 
determine presence of large number of compounds in large number of samples and to provide 
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a rapid analysis without generating false-negative results with small frequency of 
false-positive ones. Screening techniques with use of LC-MS may be targeted or non- 
targeted. Targeted methods are used to determine a list of already known analytes by 
comparison to the list of selected compounds, it usually also use reference standards. This 
approach is limited to the list of selected compounds and do not always present all compounds 
of interest. For full screening of metabolites, non-targeted analysis is used and allows to 
detect unexpected and unknown compounds (Hird et al. 2014).  
 
II.4. Industrial applications of newly identified compounds 
Many metabolites and compounds produced by bacteria and fungi find their 
applications in different fields of industry, for example, food or pharmaceutical industries. 
However, before introduction of those compounds to any field of industry, some fundamental 
bioactivity tests must be run in terms of determining the toxicity of the compound and also the 
potential influence on plant, animal and human health. Those tests include: antifungal, 
antimicrobial, antioxidant, anti- inflammatory, antitumor and phytotoxic potential tests.  
Species of Penicillium (eg. Penicillium marinum and Penicillium dravuni) and 
Talaromyces are regarded as a fruitful investigational ground for the finding of novel 
bioactive compounds, leading to the discovery of blockbuster drugs, such as the antibiotic 
penicillin and the anticholesterolemic agent compactin, miscellaneous antitumor products, and 
mycotoxins contaminating food (Nicoletti & Trincone, 2016). 
 
II.4.1. Antifungal potential 
Pathogenic fungi cause tremendous economic losses in agriculture worldwide, in all 
pre-harvest, harvest and post-harvest stages of crops and fruits as well as in animal husbandry. 
Mycotoxins contaminate and spoil foods and feedstuffs and can be deleterious for domestic 
animals and, through the food chain, even for humans. The extensive use of chemical 
fungicides in plant and animal protections can raise the resistance of fungi to those chemicals 
and can also contaminate agricultural food products.  
Biological control of fungal contamination based on microbial antagonists can be 
investigated as a possible way to improve food safety without affecting quality and properties 
of typical dry-cured meat products. Sometimes to prevent the food products from 
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exometabolites of one organism, the other organism or its metabolite is added. Due to the 
application of other harmless and non-toxic organism or metabolite, the growth of the 
pathogenic organisms or the production of toxic compounds can be inhibited (Virgili et a l., 
2012). 
In a study, presented by Virgili and collaborators, it was shown that some genera of 
non-pathogenic yeasts have antagonistic effect on fungi from genera Penicillium that grow on 
dry-cured meat products. The isolated yeasts were able of growing to high populations in 
conditions of temperature, pH, moisture, water activity and salt typical of dry-cured ham 
surface. Selected yeasts were added to dry-cured meat products as starter cultures to enrich 
the volatile compound profile. The antagonistic potential of yeasts against Penicillia has been 
already considered before for different food matrixes, such as cereals, coffee, fruits or 
fermented food like wine, cheese and yogurt (Virgili et al., 2012).  
Because of this there is an urgent need for the development of new-type and effective 
antimycotic agents. Antifungal proteins produced as exometabolites by non-cytogenic fungi 
can be promising and exploitable candidate biofungicides. Antifungal proteins produced by 
filamentous fungi are small, basic (lysine- and/or arginine-rich), cysteine-rich peptides 
stabilized by three to four disulfide bridges. Those proteins bind to the negatively charged 
plasma membrane of the sensitive organisms and may cause membrane permeabilization, 
elevation of intracellular ROS levels and, finally, the initiation of programmed cell death. The 
best studied antifungal proteins produced by filamentous fungi are AFP, secreted by 
Aspergillus giganteus, PAF from Penicillium chrysogenum and Anafp from Aspergillus niger 
(Leiter et al., 2017).  
Also the production of antimycotic substances is one of the biochemical mechanisms 
regulating antagonism between fungi. For soil fungi, for instance, it may influence fungistasis 
and the properties of certain soils toward plant pathogens. Fungi-toxic extrolites are 
considered to have their inhibitory effect in the soil environment not only on occurrence of a 
direct hyphal contact, but also over a small distance, either by diffusion or by volatilization. 
Many Penicillium species have developed competitive abilities based on the release of 
antifungals that may affect the proliferation of other pathogenic fungi. It was documented that 
P. canescens and P. janczewskii show antagonistic activity toward Rhizoctonia solani. 
Griseofulvin that was first extracted from a strain of Penicillium griseofulvum and is 
considered as an antimycotic drug (Nicoletti & Trincone, 2016), was produced by both 
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P. canescens and P. janczewskii and inhibited the hyphal growth of R. solani. (Nicoletti et al., 
2007).  
 
II.4.2. Antibacterial potential 
Fungi can be a source of natural antibiotics, which can be low-molecular weight (LMW) 
and high-molecular weight (HMW) compounds. LMW compounds are mainly secondary 
metabolites such as sesquiterpenes and other terpenes, steroids, anthraquinone and benzoic 
acid derivatives, and quinolines, but also primary metabolites such as oxalic acid. HMW 
compounds mainly include peptides and proteins (Alves et al., 2012).  
Antibiotics act in several ways, by interfering in metabolic processes or in the organism 
structures. The mechanism of action is mostly related with interferences in the synthesis of the 
cell wall, modification of plasmatic membrane permeability, interferences in chromosome 
replication, or in protein synthesis (Alves et al., 2012). 
Despite the huge diversity of antibacterial compounds, bacterial resistance to first-
choice antibiotics has been drastically increasing. Diseases that were easily healed are now 
becoming a serious problem. Because of that, natural resources have been exploited in the last 
years to find new natural sources of alternative antimicrobials. Fungi proved to be a promising 
alternative (Alves et al., 2012). 
Mycophenolic acid is famous as the first known fungal antibiotic, discovered as a 
product of a strain of Penicillium brevicompactum. It has antibiotic, antiviral, and cytostatic 
properties and is applied in medicine as an immunosuppressive drug. Gliotoxin and 
chaetoglobosins, first characterized from respectively Gliocladium fibriatum and Chaetomium 
globosum and later in few Penicillium species, show strong antibiotic/cytotoxic properties 
with a series of interesting effects on human tumor cells (Nicoletti & Trincone, 2016). 
 
II.4.3. Antioxidant potential  
Reactive oxygen species (ROS), like free radicals and other oxidants [e.g., O2•, 
1O2, 
HO•, NO•, ONOO, HOCl, RO(O)•, LO(O)•], cause major problems for human health (Prior 
et al., 2005).  
ROS are produced in metabolic and physiological processes due to oxidative chain-
reactions, but they can be neutralized via enzymatic and non-enzymatic anti-oxidative 
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mechanisms. Under some conditions, the increase in oxidants and decrease in antioxidants 
cannot be prevented, and the oxidative/anti-oxidative balance shifts toward the oxidative 
status (Ozcan, 2004).  
The production of ROS is increased in several diseases such as: diabetes, obesity, 
hypertension, atherosclerosis or cancer. Researchers are focused on finding natural sources of 
substances that could strengthen the natural antioxidant response of human organism and 
protect humans from the harmful effects of oxidant compounds. Substances with antioxidant 
properties are mostly found in plants but can be also produced by microorganisms (Cybul & 
Nowak, 2008). 
 In biological systems, there are four general sources of antioxidants: enzymes 
(superoxide dismutase, glutathione peroxidase, and catalase); large molecules (albumin, 
ceruloplasmin, ferritin, other proteins); small molecules (ascorbic acid, glutathione, uric acid, 
tocopherol, carotenoids, (poly)phenols); and some hormones (estrogen, angiotensin, 
melatonin, etc.). Individual antioxidants may sometimes act by multiple mechanisms in a 
single system or by a different single mechanism depending on the reaction system. Because 
of multiple reaction characteristics and mechanisms as well as different phase localizations 
are usually involved, no single attempt will accurately reflect all of the radical sources or all 
antioxidants in a mixed or complex system. That is why there is no simple universal method 
by which assessing antioxidant capacity (AOC) can be measured accurately and quantitatively 
(Prior et al., 2005).  The natural antioxidants are summarized in Figure II.1. 
 
Figure II.1. Natural antioxidants separated in classes (Carocho & Ferreira, 2013).  
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II.4.4. Anti-inflammatory potential 
Inflammation is a physiological response to injury, characterized by loss of function and 
pain, heat, redness and swelling. It is usually associated with the pathogenesis of diseases 
such as diabetes, arthritis, obesity, metabolic syndrome, cancer and several cardiovascular 
diseases. Uncontrolled production of inflammatory mediators has been known to cause 
several cell damages and also initiate the inflammation process. Natural products are good 
resources for development of therapeutic compounds with anti- inflammatory potential and 
without or low toxic effects (Oludemi et al., 2016).  
Macrofungi (fruiting bodies, mycelia or their submerged fermentation broth) as well as 
microfungi are rich in several bioactive compounds, either if wild, edible or cultivated 
species. These bioactive metabolites include phenolic compounds, terpenoids, 
polysaccharides, lectins, steroids, glycoproteins and some lipid components. In several studies 
it has been shown that mushrooms extracts and/or their secondary metabolites have 
antioxidant, antitumour, antimicrobial, immunomodulator, antiatherogenic, hypoglycemic and 
anti- inflammatory activities (Oludemi et al., 2016). 
It was discovered that some species of fungi like Aspergillus niger and Cunninghamella 
elegans are able to metabolize isoflavones and 4'- fluoroisoflavone. Isoflavones are the 
compounds that can be commonly found in numerous plants, especially from Leguminosae 
but recent studies revealed that some microorganisms can also produce flavones and 
isoflavones through the de novo biosynthesis (Lee et al., 2014).  
Isoflavones are molecules with many biological activities, including antioxidant, anti-
inflammatory, antitumor, and antifungal activities. Some isoflavones have also protective 
roles against pathogenic fungi and bacteria. Despite the anti-microbial roles, several fungi and 
bacteria can metabolize these compounds. The use of biological systems in transformation 
processes is a good method to increase the diversities of natural products in drug discovery, 
drug applications, food industry or enzyme preparation (Lee et al., 2014).  
 
II.4.5. Antitumor potential 
Carcinogenesis is a process in which progressive genetic changes occur leading to 
malignant transformation. Due to the technology development, currently it is possible to 
explore molecular pathways, cancer-associated genes and tissue architecture. This knowledge 
provided the basis for most cancer-preventive intervention strategies and particularly for one 
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of the strategies, chemoprevention – the use of drugs, biologicals and nutrients to prevent the 
development of cancer (i.e. to inhibit, delay or reverse carcinogenesis) (Ferreira et al., 2010).  
As mentioned before, fungal fruiting bodies, fungal mycelium or the culture fluid in 
which the mycelium has been cultivated may all be explored for biological activity. Some 
species of edible higher Basidiomycetes have shown the inhibition effect on the growth of 
different tumor cell lines. There are approximately two hundred species of higher 
Basidiomycetes that were found to have this activity. Moreover, both cellular components and 
secondary metabolites of a large number of mushrooms have been shown to affect the 
immune system. Those properties can be used in treatment of various diseases, including 
cancer, immunodeficiency diseases (including AIDS) or generalized immunosuppression after 
drug treatment (Ferreira et al., 2010).  
Macrofungi are sources of powerful new pharmaceutical products, including 
compounds with potential antitumor and immunostimulating properties, such as LMW and 
HMW compounds (Ferreira et al., 2010).  
Not only macrofungi are showing interesting antitumor properties. As mentioned 
gliotoxin and chaetoglobosins detected in a few Penicillium species show a series of 
interesting effects on human tumor cells. Also 3-O-methylfunicone, secondary metabolite 
produced by strains of Penicillium pinophilum (=Talaromyces pinophilus), was characterized 
for its cytostatic properties on a number of human tumor cell lines. It showed effects on 
cytoskeletal organization, cell cycle progression, the expression of pro-apoptotic genes, the 
inhibition of markers of tumor progression, and other mechanisms suppressing cell 
proliferation/migration (Nicoletti & Trincone, 2016). 
 
II.4.6. Phytotoxic potential 
Weeds infest economically important crops causing losses in agrarian production, 
forests, and ornamental heritages. Weed pests, including parasitic plants are one of the most 
serious agricultural and environmental problems due to competition with the growth of 
agrarian crops and forest plants by competing for water, nutrients, light and by the serious 
obstacles they represent for agronomic activities. There are many weed management 
strategies in agriculture production, including mechanical, cultural, chemical, and biological 
strategies. The use of chemical pesticides may have effects on plant toxicity, herbicidal 
resistance and environmental changes. Because of this new strategies based on the use of 
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natural products are being developed. The most popular strategy is the use of fungal 
phytotoxins alone as natural herbicides and/or in combination with fungal producers in a more 
efficient, integrated management (Cimmino et al., 2015).  
Fungal phytotoxins are secondary metabolites that have the ability to induce d isease 
symptoms in agrarian and forest plants and in weeds. They belong to different classes of 
naturally occurring compounds: aromatics, aminoacids, coumarins and isocoumarins, 
cytochalasans, ethanones, furopyrans, nonenolides, oxazatricycloalkenones, pyrones, 
spirophytotoxins, terpenes, trichothecenes, and some others with a complex and original 
carbon skeleton (Cimmino et al., 2015).  
Phytopathogenic fungi are the promising sources of toxins that may play a role in plant 
diseases and preservation of microbial species in their natural habitat.  Herbicidal-resistant 
weeds are nowadays a big problem in weed control because of the big number of weed 
biotypes resistant to herbicides that constantly increases by the continuous use of the same 
products for years. New herbicides with different mode of action are needed and phytotoxins 
produced by fungi are the promising ones (Souza et al. 2017).  
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III. MATERIALS AND METHODS 
III.1. Compound production 
P. nordicum was grown on seven media and under two temperatures to determine the 
best conditions for the production of the compound of interest, i.e., the production of high 
amounts of compound with reduced production of other metabolites, mostly ochratoxin A. 
Test conditions were selected based on previous studies (Vipotnik et al., 2017).  
The base medium was produced by boiling 5% of traditional chorizo (T) in water and 
filtering the meat extract through cheese cloth. Then, seven different media were prepared by 
adding different amounts of NaCl and glycerol, as described in Table III.1.  
A suspension of P. nordicum spores was prepared by mixing a loop full of spores from 
a 7-day old culture in 500 μL of water with 0.05% of Tween 80. All plates were inoculated by 
three-point inoculation with 3 μL of the spore suspension and incubated for 15 days at 15 ºC 
and 20 ºC (Table III.1).  
 
Table III.1. Conditions of Penicillium nordicum incubation in terms of culture medium (percentage of 
NaCl and glycerol added to the chorizo base medium) and temperature. 
Condition NaCl Glycerol 
Temperature of 
incubation (
o
C) 
TP 1.1 
3% - 
20 
TP 1.2 15 
TP 2.1 
- 2% 
20 
TP 2.2 15 
TP 3.1 
3% 2% 
20 
TP 3.6 15 
TP 4.1 
- - 
20 
TP 4.2 15 
TP 5.1 
6% - 
20 
TP 5.2 15 
TP 6.1 
- 8% 
20 
TP 6.2 15 
TP 7.1 
6% 8% 
20 
TP 7.2 15 
 
After the incubation period, 3 plugs of agar from each plate (corresponding to 0.5 g of 
medium) were cut with the aid of a cork borer and mixed with 1.5 mL of methanol for 60 
minutes, with vortexing every 15 minutes, for the extraction of the compound. The obtained 
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extracts were analyzed using an HPLC system (Smartline, Knauer, Berlin, Germany) coupled 
to a fluorescence detector (FP-2020, Jasco, Easton, MD, USA) set to λex 330 nm and λem 
463 nm and using the Clarity 2.4 Software (DataApex, Prague, Czech Rep ublic). The 
compounds were separated using an isocratic elution with a reverse-phase C18 column (100 
mm × 4.6 mm, Merck Chromolith Performance, Darmstadt, Germany) at 35 °C (7971 R 
Grace oven). The mobile phase consisted of a mixture of acetonitrile/water/acetic acid 
(70:29.5:0.5, v/v/v), with a flow rate of 0.8 mL/min. The injection volume was 10 μL.   
 The amount of the detected (unknown) metabolites was calculated as relative 
concentration equivalent of OTA, in ng/mL, by using an already existing calibration curve of 
OTA standard as reference. For the purpose of the study, the condition producing the b iggest 
amount of compound with the smallest amount of OTA (TP 4.1; base medium incubated at 
20 ºC) was selected to produce the compound in the necessary amounts for the following 
tests. For this, big amounts of extract were obtained as previously described. The extract was 
evaporated with the use of a rotative evaporator at ~60 oC and stored at 4 ºC until further use. 
The same medium but without fungal inoculation was used as negative control.  
 
III.2. Extract characterization 
The extract was analyzed at the University of Natural Resources and Life Sciences in 
Department for Agrobiotechnology in Austria by performing HPLC-ESI-MS/MS based multi-
mycotoxin method using an Agilent 1290 HPLC coupled to an Applied Biosystems QTrap 
Mass spectrometer. Screening and Quantification was performed in the Selected Reaction 
Monitoring (SRM) mode. The LC-MS/MS protocol has been published in Malachova et al. 
(2014), and has been extended to cover 710 metabolites overall. Two MRM (Multiple 
Reaction Monitoring) transitions were acquired per analyte, which yields 4 identification 
points for unambiguous identification according to Commission Decision 2002/657/EC. In 
addition, the retention time and the intensity ratio of the two MRM transitions has to agree 
with the related values of an authentic standard within 2.5 % rel. and. 30% rel., respectively.  
The sample was diluted 1+19 using acetonitrile/water 1/1 + 1% acetic acid and 5 µL were 
directly injected. 
External calibration was performed using serial dilutions of a multi-analyte stock 
solution. Limits of detection (LOD) in the standards were calculated from the signal-to-noise 
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ratios (LOD = 3 * S/N). From these values, the LODs in the diluted liquid sample were 
calculated taking into account the dilution factor.  
 
III.3. Evaluation of bioactive properties of extract 
 
III.3.1 Evaluation of antioxidant activity 
III.3.1.1. DPPH radical scavenging activity 
The extract was dissolved in methanol at 5 mg/mL, and further diluted into sequential 
concentrations. DPPH (2,2-diphenyl-1-picryl-hydrazyl) radical-scavenging activity was 
evaluated using an ELX800 microplate reader. In each well it was added 30 μL of each 
concentration of the extract and 270 μL of methanolic solution containing DPPH radicals 
(610-5 mol/L). The reduction of DPPH was determined after 1 h of reaction in the dark, by 
measuring the absorption at 515 nm. The radical scavenging activity (RSA) was calculated as 
a percentage of DPPH discoloration using the equation:  
%RSA=[(ADPPH  AS)/ ADPPH] × 100 
where ADPPH is the absorbance of DPPH solution and AS is the absorbance extract solution 
(Carocho et al. 2014). 
III.3.1.2. Reducing power  
The reducing power (RP) assay was also performed using the Microplate Reader 
mentioned above. Each concentration of the extract (0.5 mL) was mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% (w/v), 
0.5 mL). The mixtures were incubated at 50 oC for 20 min and trichloroacetic acid (10% 
(w/v), 0.5 mL) was added. The mixture (0.8mL) was transferred into the wells, as also 
deionized water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL).  The reducing power was 
evaluated by measuring the capacity of the extract to reduce Fe3+ to Fe2+ by measuring the 
absorbance at 690 nm (Barros et al. 2010).  
III.3.1.3. Inhibition of β-carotene bleaching 
Inhibition of β-carotene bleaching (βC) was evaluated through the β-carotene/linoleate 
assay. In this assay, the bioactive samples neutralize the linoleate free radicals, reducing 
β-carotene discoloration (Carocho et al. 2014a).  
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A solution of β-carotene was prepared by dissolving β-carotene (2 mg) in chloroform 
(10 mL). Two milliliters of prepared solution was transferred into round-bottom flask and 
evaporated at 40 oC. After evaporation under vacuum, Tween 80 emulsifier (400 mg), lionelic 
acid (40 mg) and distilled water (100 mL) were added with vigorous shaking. Different 
concentrations of extract (0.2 mL) were put in the test tubes and prepared emulsion was added 
(4.8 mL). Control was prepared by adding the extraction solvent (0.2 mL) instead of the 
extract into the emulsion (4.8 mL). As soon as the emulsion was added, initial absorbance was 
measured at 470 nm and tubes were incubated in a water bath at 50 oC with agitation 
(100 rpm) for 2 h. Reduction of discoloration was measured after 2 h at 470 nm and 
calculated using the formula:  
% = [AβC_2h/ AβC]  100 
where AβC_2h is the absorbance after 2 h of assay and AβC is the initial absorbance (Barros et 
al. 2010). 
 
III.3.1.4. Inhibition of lipid peroxidation using thiobarbituric acid reactive substances 
(TBARS) 
The thiobarbituric acid reactive substances (TBARS) assay used porcine brain 
homogenates that react with ascorbic acid to create the malondialdehyde - thiobarbituric acid 
(MDA-TBA) (Carocho et al. 2014a).  
The porcine brain was homogenized with Tric-HCl buffer (20 mM, pH 7.4), to produce 1:2 
(w/v) brain tissue homogenate which was later centrifuged at 3000 g for 10 min. Different 
concentrations of extract (0.2 mL) were transferred into test tubes and FeSO4
+ (10 μM, 
0.1mL), ascorbic acid (0.1 mM, 0.1 mL) and supernatant of brain tissue homogenate (0.1 mL) 
were added. Two controls were performed, one with extraction solvent (methanol) and other 
with the Tris-HCl buffer (20 mM, pH 7.4) with addition of reagents mentioned before (except 
extract). All tubes were incubated at 37 oC for 1 h. The reaction was stopped by the addition 
of trichloroacetic acid (28% (w/v), 0.5 mL), followed by thiobarbituric acid (TBA, 2% (w/v), 
0.38 mL). Then the mixture was heated at 80 oC for 20 min and centrifuged at 3000 g for 10 
min.   
The inhibition of lipid peroxidation was measured by colorimetric assay at 532 nm using the 
formula:  
% = [(A  B)/A]  100 
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where A and B are respectively the absorbance of the control and of the extract solution 
(Barros et al. 2010). 
The results of the antioxidant activity were expressed in EC50 values (sample concentration 
providing 50% of antioxidant activity or 0.5 of absorbance in the reducing power assay).  
 
III.3.2. Evaluation of the cytotoxic properties in tumor and non-tumor cells  
The cytotoxicity was tested on four human tumor cell lines: MCF7 (breast 
adenocarcinoma), NCI H460 (lung carcinoma), HeLa (cervical carcinoma) and HepG2 
(hepatocellular carcinoma). The density of cells on 96-well plates was 7.5  103 cells/well for 
MCF7 and HCT15, and 1.0  104 cells/well for HeLa and HepG2. Further, different 
concentrations of extract (8, 2, 0.5 0.125 mg/mL) diluted in distilled water were added to 
prepared cells. The cytotoxicity was also tested on non-tumor cells, using a cell culture 
prepared from fresh liver of porcine (PLP2), which was slaughtered in a certified facility.  A 
phase-contrast microscope was used to monitor the growth of the cell cultures. They were 
sub-cultured and plated in 96 well plates (density of 1.0  104 cells/well). DMEM (Dulbecco's 
Modified Eagle Medium) medium was used, with 10% of FBS (Fetal Bovine Serum),  
penicillin (100 U/mL) and streptomycin (100 μg/mL). Ellipticine was used as a standard, and 
the results were expressed in GI50 values in μg/mL (sample concentration that inhibited 50% 
of the net cell growth) (Carocho et al., 2014b). 
 
III.3.3. Evaluation of the antibacterial activity 
To determine the antibacterial activity, Gram-negative (G-) and Gram-positive (G+) 
bacteria were used. The G- bacteria used were: Escherichia coli, Pseudomonas aeruginosa, 
Klebsiella pneumoniae and Morganella morganii, and G+ bacteria were: Enterococcus 
faecalis, Listeria monocytogenes and Staphylococcus aureus. A fresh overnight culture of 
bacteria was adjusted with a spectrophotometer at 625 nm to a concentration of 1 × 105 
CFU/mL (colony forming units). The extract solutions (in concentrat ions of: 20, 10, 5, 2.5, 
1.250, 0.625 and 0.315 mg/mL) were pipetted into the wells containing Tryptic Soy Broth 
(TSB) (100 μL). After that, the inoculum (10 μL) was added to all the wells. The microplates 
were incubated for 24 h at 37 °C, followed by the addition of iodonitrotetrazolium chloride 
(INT) (0.2 mg/mL, 40 μL) and by incubation at 37 °C for 1 h. MIC (minimal inhibitory 
concentration) was determined visually by a colorimetric microbial viability assay based on 
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the reduction of INT color and compared with the positive control for each bacterial strain. 
Streptomycin and ampicillin were used as standards, while medium extract was used as a 
negative control (Carocho et al. 2015). 
 
III.3.4. Evaluation of the antifungal activity 
The antifungal activity test was performed using the following microfungi: Aspergillus 
fumigatus, Aspergillus ochraceus, Aspergillus versicolor, Aspergillus niger, Aspergillus 
terreus, Aspergillus flavus, Penicillium funiculosum, Penicillium ochrochloron, Penicillium 
verrucosum var. cyclopium and Trichoderma viride.  
The micromycetes were maintained on malt agar (MA) and the cultures were stored at 
4°C and sub-cultured once a month. The fungal spores were washed from the surface of agar 
plates with sterile 0.85% saline containing 0.1% Tween 80 (v/v). The spore suspension was 
adjusted with sterile saline to a concentration of approximately 1.0 × 105 in a final volume of 
100 μL per well. The inocula were stored at 4 °C for further use. Dilutions of the inocula were 
cultured on solid MA to verify the absence of contamination and to check the validity of the 
inoculum. The minimum inhibitory concentrations (MIC) were determined by a serial dilution 
of the extract using 96-well microplates. The extract solutions were added to the broth malt 
medium with the fungal inoculum. The microplates were incubated for 72 h at 28 °C. The 
lowest concentrations without visible growth (using a binocular microscope) were defined as 
the MIC. The minimum fungicidal concentrations (MFC) were determined by serial sub-
cultivation of 2 μL of the previous suspensions in microtiter plates containing 100 μL of malt 
broth per well and further by incubation for 72 h at 28 °C. The lowest concentration with no 
visible growth was defined as the MFC, indicating 99.5% killing of the original inoculum. 
Culture medium was used as a negative control, while bifonazole and ketoconazole were used 
as standards (Carocho et al. 2015).  
 
III.3.5. Preliminary evaluation of phytotoxicity 
Herbicidal activity test was performed on Schulz Medium (SM; Table III.2) with the 
addition of the extract in the concentration of 15 mg/mL dissolved in distilled water. SM was 
used as negative control. Plant seeds used for the test were: Solanum lycopersicum (tomato), 
Lactuca sativa (lettuce), Triticum aestivum (common wheat) and Avena sativa (oat). All seeds 
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used were previously surface-disinfected in 10% bleach for 2 min and washed twice with 
sterile water.  
Table III.2. Content of Schulz Medium (SM).  
Reagent Concentration 
KH2PO4 • 3H2O 0.25 g/L 
KCl 0.25 g/L 
MgSO4 • 7H2O 0.25 g/L 
Ca(NO3)2 1.00 g/L 
EDTA 20.0 mg/L 
agar 8.00 g/L 
 
Two millilitres of each media were poured in large test tubes and two seeds of each 
plant were inoculated on the media. Each plant was tested in four repetitions on each medium. 
Tubes were incubated in an in vitro culture room with photoperiod with variable temperature 
(17 h of light at 25 oC and 7 h of dark at 15 oC) for 10 days. Seed germination and growth of 
each plant were monitored daily. Root and shoot growth were visually measured from the 
outside of the tube after 2, 3, 4, 5, 8, 9, 10 and 14 days of incubation. At the end of this 
period, plants were taken out of the tubes, separated from the medium by slight heating and 
measured with the aid of a ruler. The number of roots and leaves was also registered. Results 
were expressed in % of growth reduction of roots and shoot for each plant.  
Statistical analysis was performed using IBM® SPSS® Statistics v.22.0 software 
(Armonk, NY: IBM Corp.). The variables under study did not show a normal 
distribution, therefore the non-parametric statistical U-Mann Whitney test was used for 
comparison of means. In all cases, statistical significance was established at  p ≤ 0.05. 
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IV. RESULTS AND DISCUSSION 
IV.1. Compound production 
 
Fungal growth was observed at all tested media. The growth of P. nordicum on chorizo-
based medium after an incubation period of 14 days at 20 ºC is shown in Figure IV.1. 
 
Figure IV.1. Growth of Penicillium nordicum on chorizo-based medium (5% chorizo extract), without 
NaCl and glycerol added (TP4.1), after 14 days of incubation at 20 ºC. 
 
HPLC analysis showed that P. nordicum grown on different media produced different 
types of metabolites and at different amounts (Figure IV.2). The retent ion time of the 
compound of interest was around 4.45 min. Under some conditions, OTA was also detected, 
at retention time 2.45 min, as compared with the standard solution. The relative amounts of all 
detected metabolites (as OTA equivalents, in ng/mL), including that of the compound of 
interest and OTA, are presented in Figure IV.3.  
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Figure IV.2. Comparison of two HPLC- FLD chromatograms where OTA and compound of interest 
were produced in different amounts under different conditions: (A) TP 4.1 - medium containing 5% 
chorizo extract, incubated in 20 
o
C; (B) TP 4.2 - medium containing 5% chorizo extract, incubated at 
15 
o
C. 
 
 
Figure IV.3. Relative concentration of metabolites (as OTA equivalents, in ng/mL) produced by 
Penicillium nordicum on the different tested conditions. 
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The highest amount of the target compound was produced on TP4.1 medium, containing 
5% of chorizo extract (no NaCl and glycerol added) and incubated at 20 oC, with only 
negligible amounts of OTA being produced (Figure IV.2A). Under some other culture 
conditions (TP 2.2, TP 4.2; Figure IV.2B), OTA production was detected. The condition 
TP4.1 was considered as the most adequate to be used for the production of the compound in 
big amounts for further tests, because it was the condition where the highest amount of 
compound and lowest amount of OTA were produced, with the advantage of being the most 
cost-effective one (no NaCl and glycerol added; less energy spent on refrigeration).  
 
IV.2. Extract characterization  
The analysis of the extract by the multi-metabolite detection method detected three 
metabolites present at concentrations higher than the quantification limit of the method: 
Pestalotin (52 ng/mL), Questiomycin (39.4 ng/mL) and 7-Hydroxypestalotin (15.3 ng/mL). 
All other investigated metabolites were below their limit of detection (Appendix I). Figure 
IV.4 represents the LC-MS chromatogram of the extract, showing the three detected 
metabolites (Figure IV.4A).  
The enhanced mass spectrum of the protonated species ([M+H]+; m/z=215) of pestalotin 
and the corresponding product ion scan for the precursor ion (m/z=153) is shown in Figure 
IV.4B. Figure IV.5 shows the chemical structure of pestalotin.  
Pestalotin (also known as compound LL-P880α; Kirihata et al., 1986), which was 
present in the extract in the biggest amount, was already known to be produced by 
P. nordicum and the compound is considered to have herbicidal activity (Frisvad, 2004) and 
to be a potent gibberellin-synergist on rice seedlings (Kirihata et al., 1996). 
Gibberellins are plant hormones that regulate growth and influence stem elongation and seed 
germination. In a study by Kimura et al. (1971) it was proven that the promotive effect of 
gibberellins on release of reducing sugar was enhanced by the simu ltaneous addition of 
pestalotin, promoting shoot growth of Oryza sativa (rice).  
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Figure IV.4. Enhanced product ion scan for the precursor ion m/z=215 (protonated species of 
pestalotin). (A) LC-MS chromatogram of the extract; (B) Enhanced Product Ion Spectrum of 
pestalotin (m/z=153). 
 
 
 
Figure IV.5. Chemical structure of pestalotin (LL-P880α) (Kirihata et al., 1996).  
 
A
B
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The enhanced mass spectrum of the protonated species ([M+H]+; m/z=213) of 
questiomycin and the corresponding product ion scan for the precursor ion (m/z=156) is 
shown in Figure IV.6. Figure IV.7 shows the chemical structure of the compound.  
 
Figure IV.6 Enhanced Product Ion Scan for m/z=213 (protonated species of questiomycin). (A) LC-
MS chromatogram of the enhanced product; (B) Enhanced Product Ion Spectrum of questiomycin 
(m/z=156). 
 
 
Figure IV.7. Chemical structure of Questiomycin A (2-amino-3H-phenoxazine-3-one) (Kozlovsky et 
al., 2004). 
 
A
B
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Questiomycin, the second most abundant compound detected in the extract, is a 
phenoxazine that was discovered in several strains of actinomycetes, bacteria, and the fungus 
P. chrysogenum Thom. Phenoxazinones of various structures are chromophore moieties of 
antibiotics produced by various actinomycetes. (Kozlovsky et al., 2004). Questiomycin shows 
weak activity against bacteria, fungi, plants and tumor cell lines, and inhibits aromatase and 
sulfatases. Questiomycin, like other phenoxazines, stimulates cell growth and turnover in 
vitro, an activity possibly related to their ability to form stable free radicals (www.scbt.com).  
 
7-hydroxypestalotin ((-) - (6S ,I'S, 2'R) - 6 - (1', 2'- Dihydroxypentyl) - 4- methoxy - 
5,6-dihydropyrane-2-one, also known as LL-P880β), a minor analog metabolite of pestalotin, 
was the less abundant of the three quantifiable compounds detected in the extract. Its chemical 
structure is represented in Figure IV.8. The MS spectrum of 7-hydroxypestalotin was not 
obtained. 
7-hydroxypestalotin was first isolated from an unidentified Penicillium species and in 
1986 was isolated from a culture filtrate of Penicillium citreo-viride by Kimura and co-
workers (Kimura et al. 1986). Unlike pestalotin, this compound hardly shows gibberellin 
synergist activity (Kirihata et al., 1996).  
 
Figure IV.8. Chemical structure of 7-hydroxypestalotin ((-) - (6S ,I'S, 2'R) - 6 - (1', 2'- 
Dihydroxypentyl) - 4- methoxy - 5,6-dihydropyrane-2-one, LL-P880β) (Kirihata et al. 1996). 
 
Technique used for determining extract composition was targeted LC-MS analysis. 
Extract was screened for unknown compounds and was compared to the list of reference 
compounds. However, because of the use of targeted approach, some compounds, since the y 
were not present on the list of reference, might not be identified. 
Non-targeted LC-MS analysis is more time consuming and requires more effort than 
targeted one but it allows to determine compounds in the extract that normally, with the use of 
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conventional targeted analysis, would not be determined. The disadvantage of non-targeted 
analysis is the quite big frequency of occurrence of false negatives because it is impossible to 
determine if a compound is sufficiently recovered during the analytical procedure or is not 
ionized as expected. For non- targeted analysis on unknown analytes the MS/MS analysis 
must to be performed separately in terms of selection of precursor ion from TIC (total ion 
current). Further chosen precursor ion must be fragmentized via CID (collision- induced 
dissociation) and the product ions are scanned. Targeted LC-MS approach is faster and allows 
rapid monitoring of hundreds of analytes. Targeted technique coupled with MS/MS is used to 
limit false positive results by searching against mass spectra libraries (Hird et al. 2014).  
 
IV.3. Evaluation of bioactive properties of the extract 
IV.3.1. Evaluation of antioxidant activity 
The antioxidant activity of the extract was determined through various assays: DPPH 
scavenging activity, reducing power (RP) through Prussian-blue assay, inhibition of 
 -carotene bleaching, and inhibition of TBARS formation in brain cell homogenates.  
The extract showed antioxidant activity only in RP assay: 0.5 of absorbance at 690 nm 
at a concentration of 2.5 mg/mL. For the other performed assay, it was not possible to 
determine the EC50 values (results presented in Table IV.1).  In DPPH scavenging assay as 
well as in TBARS analysis, already on the microplates, no significant change of color, in 
comparison to positive controls, was noticed (Figures IV.9 - 10). 
 
Table IV.1. Antioxidant activity of the extract 
Antioxidant activity EC50 values [mg/mL] 
DPPH scavenging activity > 5 
Reducing power 2.5 
β-Carotene bleaching inhibition > 5 
TBARS inhibition > 5 
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Figure IV.9. DPPH scavenging analysis with the use of ELX800 microplate Reader (Bio-Tek 
Instruments, Inc.; Winooski, VT, USA); extract: wells 2-4 A-G, culture medium (negative control): 
wells 6-8 A-G; methanol (positive control): wells 2-4, 5-8 H. 
 
 
 
Figure IV.10. TBARS assay analysis with the use of ELX800 microplate Reader (Bio-Tek 
Instruments, Inc.; Winooski, VT, USA); extract: wells 1-2 A-F, culture medium (negative control): 
wells 3-4 A-F; Tris (positive control): wells 5-6 A, methanol (positive control): wells 5-6 B. 
 
In the study presented by Canturk et al. (2017) it was proven that among 82 isolates 
from Penicillium genus only 28.2% of them showed antioxidant activity in DPPH scavenging 
activity test. P. flavigenum was one of the species that showed the highest antioxidant activity 
effect.  
Many secondary metabolites, with antioxidant activity, produced by microfungi from 
Penicillium sp. found their applications in different fields of industry in order to drug 
production (Canturk et al. 2017). For that reason compound extract obtained in this study 
from P. nordicum was examined in terms of antioxidant activity. Nonetheless obtained results 
proved that tested extract did not show antioxidant activity.  
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IV.3.2. Evaluation of the cytotoxic properties 
Cytotoxicity was tested on four human tumor cell lines: MCF7 (breast 
adenocarcinoma), NCl H460 (lung carcinoma), HeLa (cervical carcinoma) and HepG2 
(hepatocellular carcinoma). The results are presented in Table IV.2. The extract did not show 
activity against any of the tumor cell lines tested, up to the maximal tested concentration. Also 
no hepatotoxicity was detected for the PLP2 (non-tumor porcine liver cells).  
 
Table IV.2. Cytotoxic activity of the extract performed on tumor and non-tumor cell lines. 
Antitumor activity GI
50
 [μg/mL] 
MCF7 >400 
NCl H460 >400 
HeLa >400 
Hep G2 >400 
Hepatotoxicity 
 
PLP2 >400 
 
In a study by Luo et al. (2012), pestalotin and 7-hydroxypestalotin were detected in a 
fermentation broth of the endophytic plant fungus Pestalotiopsis karstenii isolated from stems 
of Camellia sasanqua. These compounds displayed strong activities against the cell line U-
251 (human glioma cell line), with IC50 values of 2.5 and 12.0 μg/mL, respectively, but 
showed no activity against HeLa, A549, HepG2 and MCF-7 cell lines. 
Many Penicillium species are well known for mycotoxins and antibiotic production that 
present cytotoxic effects and may have direct or indirect implications in cell division, showing 
the fundamental properties of typical antitumor products. However, some compounds such as 
citrinin, ochratoxin A, patulin, penicillic acid, alternariol and PR-toxin, produced by 
Penicillium sp. cannot be applied in pharmaceutical industry because of their high toxicity 
(Nicoletti et al. 2008). 
  In studies presented by Nicoletti et al. (2008, 2016), it was proven that many 
secondary metabolites produced by Penicillium sp. show significant antitumor activities. 
P. nordicum was not mentioned as one of the producers of antitumor extrolites. For that 
reason after obtaining extract of unknown secondary metabolite from P. nordicum it was 
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needed to check its potential cytotoxicity in terms of pharmaceutical applications. 
Nonetheless extract did not show any cytotoxic activities.  
 
IV.3.3. Evaluation of antimicrobial activity against bacteria and fungi  
The extract was tested against various Gram positive and Gram negative bacteria, and 
fungi. Medium extract was used as the negative control. MIC and MFC (for fungi) were 
determined and presented in Tables IV.3 and IV.4.  
 
Table IV.3. Antibacterial activity of compound extract and culture medium; MIC- minimal inhibitory 
concentration; ESBL- spectrum extended producer of β- lactamases. 
MIC (mg/mL) 
  
Bacteria strains Test extract 
Negative control 
(medium extract) 
Gram +   
Enterococcus faecalis >20 >20 
Listeria monocytogenes >20 >20 
Methicillin susceptible Staphylococcus 
aureus 
>20 >20 
Methicillin resistant  Staphylococcus 
aureus 
>20 >20 
Gram -   
Escherichia coli ESBL >20 >20 
Escherichia coli >20 >20 
Klebsiella pneumoniae  ESBL >20 >20 
Klebsiella pneumoniae >20 >20 
Morganella morganii >20 >20 
Pseudomonas aeruginosa >20 >20 
 
For antibacterial activity test extract did not show activity for the concentrations tested. 
However, in antifungal activity test, among all tested fungi, extract showed inhibitory and 
fungicidal activity against A. ochraceus and T. viride, with MIC value of 0.075 mg/mL and 
MFC value of 0.15 mg/mL for both fungi. For A. versicolor, A. niger, A. terreus, A. flavus and 
P. ochrochloron, the extract showed inhibitory and fungicidal activity higher than those 
observed by ketoconazole, but lower than bifonazole. For that reason, the extract was not 
considered to have significant antifungal activity against those strains.  
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Table IV.4. Antifungal activity of compound extract; MIC (mg/mL) - minimal inhibitory 
concentration; MFC - minimal fungicidal concentration; *MFC (mg/mL) were not determined due to 
insufficient amount of sample 
Fungal strains 
Test Extract 
MIC/MFC 
Neg. control 
(Medium extract) 
MIC/MFC 
Bifonazole 
MIC/MFC 
Ketoconazole 
MIC/MFC 
Aspergillus fumigatus 0.30/0.60 0.60/0.90 0.15/0.20 0.20/0.50 
Aspergillus versicolor 0.15/0.30 0.30/0.90 0.10/0.20 0.20/0.50 
Aspergillus ochraceus 0.075/0.15 0.20/0.60 0.15/0.20 1.50/2.00 
Aspergillus niger 0.15/0.30 0.60/0.90 0.15/0.20 0.20/0.50 
Aspergillus terreus 0.15/0.30 0.60/0.90 0.15/0.20 0.50/1.00 
Aspergillus flavus 0.30/0.60 0.60/1.20 0.20/0.25 1.00/1.50 
Trichoderma viride 0.075/0.15 0.30/0.60 0.15/0.20 1.00/1.00 
Penicillium funiculosum 0.60/* 0.90/* 0.20/0.25 0.20/0.50 
Penicillium ochrochloron 0.60/* 0.90/* 0.20/0.25 2.50/3.50 
Penicillium verrucosum 0.90/* 1.20/* 0.10/0.20 0.20/0.30 
 
Some fungi from genera Penicillium are able to produce very high number of antibiotic 
and antifungal compounds (Frisvad et al. 2004). In study presented by Frisvad et al. 2004 it 
was shown how big number of biologically active exometabolites is produced  by Penicillium 
species. 
In structure elucidation study it was determined that one of compounds present in quite 
big amounts was questiomycin, being known as an antibiotic. However antibacterial study did 
not show any antibiotic activity of the extract.  
 
IV.3.4. Preliminary evaluation of phytotoxic activity 
Phytotoxic activity of the extract was analyzed on a preliminary test on four different 
plants: two dicotyledonous - Solanum lycopersicum (tomato) and Lactuca sativa (lettuce) -, 
and two monocotyledonous - Triticum aestivum (common wheat) and Avena sativa (oat). 
Plantlets of the four plant species tested, obtained after 10 days of growth on SM (negative 
control, medium without extract) and SM-X (medium with extract added) are presented  in 
Figure IV.11. The extract effect on the root and shoot growth is shown in Figures IV.12 and 
IV.13.  
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Figure IV.11. Plantlets of the four plant species tested, obtained after 10 days of growth on SM (left of 
the ruler) and SM with the extract (right).  
 
Tomato
Lettuce
Wheat
Oat
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Figure IV.12. Effect of the extract on the roots growth of tested plants in comparison with control 
(SM). 
 
 
Figure IV.13. Effect of the extract on the shoot growth of tested plants in comparison with control 
(SM). 
 
The root growth inhibition ranged from 65.9% to 100%, and the shoot growth was 
reduced in 22.7% to 92%, being tomato the most sensitive plant (Table IV.5). The standard 
deviation was calculated and it showed quite big values. That big deviation might be caused 
by some contaminations of the seeds and also lack of homogeneity between the seeds of each 
species.  
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Table IV.5. Comparison of root and shoot growth inhibition of tested plants in comparison to control 
(SM); n=6 (for each plant)  sd 
 
root growth reduction [%] shoot growth reduction [%] 
tomato 100.0  0.0 92.1  11.0 
lettuce 65.9  12.8 55.9  30.4 
wheat 76.4  6.7 22.7  13.2 
oat 75.3  14.1 37.1  27.1 
 
Statistical analysis was performed to compare means in terms of influence of the extract 
on growth of roots and shoot of tested plants (Table IV.6). Statistical analysis was also 
performed to compare the growth reduction between the species (Table IV.7). Statistical 
significance was established at p ≤ 0.05. 
 
Table IV.6. Statistical analysis of means in terms of influence of the extract on roots and shoot growth 
of tomato, lettuce, wheat and oat. 
 
p-value 
 
tomato lettuce wheat oat 
number of roots 0.001 1.000 0.279 1.000 
number of leaves 0.001 0.040 0.161 0.345 
length of roots 0.001 0.009 0.083 0.043 
length of shoot 0.001 0.002 0.105 0.043 
 
Table IV.7. Statistical comparison between species in terms of growth reduction.  
 p- value 
 reduction of root length reduction of shoot length 
tomato x lettuce 0.001 0.007 
tomato x wheat 0.005 0.032 
tomato x oat 0.002 0.002 
lettuce x wheat 0.289 0.293 
lettuce x oat 0.113 0.269 
wheat x oat 0.596 0.358 
 
Statistical analysis showed that the extract has the significant influence on root and 
shoot growth of tomato, lettuce and oat, by inhibiting their growth. It also significantly 
influenced the number of roots and leaves of tomato and number of leaves of tomato and 
lettuce. Wheat appeared to be the most resistant to the inhibitory effect of the extract.  
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The comparison between species confirmed that the tomato was the most sensitive one, 
on the effect of the extract, between tested plants. The most significant difference between 
species in terms of growth inhibition of roots and shoot was between tomato and oat (p= 
0,002).  
Observed inhibitory effect was probably caused because of big amount of pestalotin in 
the extract (see IV.2.), that is considered as the potential herbicide (Frisvad, 2004) with 
gibberellin-synergist action (Kirihata et al., 1996). Basing on the results presented on Figures 
IV.10 and IV.11 it was determined that compound extract affected mostly roots of all tested 
plants.  
Nowadays production of new bioherbicides is essential because of limited traditional 
chemical control options due to ecodegradation, health hazards, and the development of 
herbicide resistance in weeds (Souza et al. 2017). In the study presented by Souza et al. 
(2017) it was proven that 28 from 39 tested fungi showed herbicidal activity resulting in 
growth inhibition of aerial parts, reduction of height and fresh weight.  
Fungal phytotoxins have the ability to induce disease symptoms in agrarian and forest 
plants and in weeds. They belong to different classes of naturally occurring compounds and 
are used as biocontrol agents to manage weeds on agriculture crops causing large necrosis on 
leaves and stems and also a retarded growth or death of plants (Cimmino et al. 2015). In the 
study of Cimmino et al. (2015) it was proven that most of tested fungal phytotoxins showed 
strong herbicidal activity without showing toxicity against terrestrial microorganisms and 
animals. It was also determined that the use of mixture of few phytotoxins except one showed 
better effects on weed growth inhibition also without showing antifungal, antibiotic and 
zootoxic activities. In comparison to the chemical herbicides, bioherbicides are safer for the 
environment simultaneously showing high herbicidal effects.  
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V. CONCLUSIONS AND PERSPECTIVES 
Examined extract showed herbicidal activity without showing strong antimicrobial and 
cytotoxic properties. For that reason extract is considered to be a new promising bioherbicide. 
Further herbicidal activity assays are being performed on tested extract. It was shown that 
dicots (tomato and lettuce) are more vulnerable to inhibitory effects of the extract then 
monocots (wheat and oat). Since extract is considered as a potential herbicide, further toxicity 
analysis must to be performed against insects. It is very important in terms of possible 
agricultural applications.  
Although many fungal metabolites showed potential herbicidal activity, their tests in 
greenhouses and in the open field are still very limited. Also the transfer to industry for large 
scale production and their application into practice as commercial products are still 
problematic due to lack of funding and low yields in production.   
For the industrial scale-up of phytotoxins an optimization of the production process in 
the fermenter is needed. However, fermenters, widely used for the bacteria for the large scale 
antibiotics production, also need to be developed to avoid the adhesion of the mycelia masses 
to the walls and the poles of the bioreactor.  
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Appendix I 
Limits of detection of the investigates analytes (expressed as ng/mL sample taking into 
consideration the dilution factor; n.a.: not available due to lack of a quantitative reference 
standard) 
Analyte LOD (ng/mL) 
15-Acetyldeoxynivalenol 6 
15-Hydroxyculmorin 2 
15-Hydroxyculmoron 12 
15-Methyl_epi_Fumiquinazolin A n.a. 
15-Monoacetoxyscirpenol 0.8 
16-Ketoaspergillimide  0.28 
2-Chlorunguinol 0.032 
3-Acetyldeoxynivalenol 0.6 
3-Nit ropropionic acid  0.4 
3-O-Methylvirdicatin  0.08 
4-Hydroxyalternariol 1 
4-Monoacetoxyscirpenol n.a. 
5-Hydroxyculmorin  20 
5-Methylmellein  3 
7-Hydroxypestalotin 0.2 
A 23187 n.a. 
AAL TA Toxin  2.4 
Abscisic acid 0.8 
Acetyldeoxypentahydroxyscirpenol n.a. 
Acetylpentahydroxyscirpenol n.a. 
Aflatoxico l 1 
Aflatoxin B1 0.12 
Aflatoxin B2 0.2 
Aflatoxin G1  0.16 
Aflatoxin G2  0.4 
Aflatoxin M1 0.2 
Aflatoxin M2 n.a. 
Aflatoxin P1 1.2 
Aflatrem n.a. 
Aflavarin  n.a. 
Agistatin B 4 
Agistatin D 2.8 
Agistatin E 1.32 
Agroclavine 0.12 
Aigualomycin D 1 
Alamethicin F30 0.4 
alpha-Zearalenol 0.4 
alpha-ZOL-Glucosid 1.2 
Alteichin  n.a. 
Altenuene 0.28 
Altenusin 32 
Alternarian acid 40 
Alternario l 0.2 
Alternario l-3-glucoside 0.4 
Alternario l-9-glucoside 0.4 
Alternario lmethylether 0.016 
Alternario lmethylether-glucoside 4 
Altersetin 0.2 
Altersolanol 12 
Altertoxin-I 0.4 
  
Altertoxin II n.a. 
Amidepsin B 0.6 
Aminooctadecyldecan-3-ol 2.4 
Amoxycillin n.a. 
Amphotericin  n.a. 
Anacin 3.2 
Andrastin A 0.08 
Andrastin B 0.2 
Andrastin C n.a. 
Andrastin D n.a. 
Anisomycin 0.08 
Anomalin A n.a. 
Antibiotic F 1849 A  0.4 
Antibiotic L 696474 8 
Antibiotic PF 1052 0.8 
Apicidin  0.06 
Ascochlorin 0.08 
Ascomycin  1.2 
Asparason A n.a. 
Aspercolorin  0.4 
Asperfuran 8 
Aspergamide A 1 
Aspergillicin Derivat 0.4 
Aspergillin PZ n.a. 
Aspergillimide  0.08 
Asperglauccide 0.04 
Asperlactone 0.016 
Asperloxin A 0.4 
Asperphenamate 0.02 
Asperthecin n.a. 
Aspinolid B 0.32 
Aspinonene n.a. 
Aspochalasin C 0.8 
Aspochalasin D 0.8 
Aspochalasin I 2 
Aspochalasin J 2 
Aspterric acid 4 
Aspyrone 16 
Asterric acid  1.6 
Asteltoxin  1 
Atpenin A5 0.028 
Atroventinmethylether 0.6 
Aurantiamin A 0.32 
Auranticin A 2 
Aurasperon B n.a. 
Aurasperon C n.a. 
Aurasperon G n.a. 
Aureobasidin A 1.6 
Aurofusarin 1.2 
Austalide A 0.4 
Austalide B 0.4 
Austalide D 1 
Austalide F 1 
Austamide 0.32 
Austdiol n.a. 
Austocystin A 0.8 
Austocystin D 1 
Austocystin I 1.6 
  
Avenacein Y 20 
Averantin 0.02 
Averantinmethylether 0.032 
Averufanin 0.032 
Averufin 0.032 
Averufin-Derivat  0.2 
Bacit racin  n.a. 
Bafilomycin A1 0.16 
Barceloneic acid A 3.2 
Bassianolide 0.2 
Beauvericin 0.004 
Benzomalvin A  4 
Benzomalvin C 1 
Berkedrimane B 0.2 
Berkeleyacetal B 60 
beta-Zearalenol 0.6 
beta-ZOL-Glucosid 1.2 
Bikaverin  4 
Bis(dethio)methylthiogliotoxin  0.4 
Bismethylgliotoxin  2 
Botryan-Derivat n.a. 
Brasiliamide A 1.2 
Brefeld in A 8 
Brev ianamid F 0.08 
Brev icompanine B 0.4 
Butenolid  2.8 
Butyrolacton I 4 
Butyrolacton II 2 
Butyrolacton III 1 
Calonectrin 2.8 
Calphostin C 2 
Calyxanthone 4 
Cephalochromin  n.a. 
Cephalosporin C n.a. 
Cercosporamide 0.1 
Cercosporin 6 
Cereu lide  0.2 
Ceru lenin  40 
Chaetocin 6 
Chaetoglobosin A 40 
Chaetoglobosin D 40 
Chaetomin  8 
Chaetovirid in A 0.4 
Chanoclavine 0.04 
Chetoseminudin n.a. 
Chevalone C 0.12 
Chlamydospordiol 0.08 
Chlamydosporol 0.4 
Chloramphenico l 0.06 
Chlorocitreorosein 1 
Chloronectrin  0.08 
Chlortetracyclin  n.a. 
Chrodrimanin  4 
Chromomycin A3 n.a. 
Chrysogine 0.2 
Chrysophanol 4 
Citreorosein 0.32 
Citreoviridin A  2 
  
Citreoviridin C n.a. 
Citreoviridinol n.a. 
Citrin in  0.08 
Citromycetin 10 
CJ 21058 0.06 
Cladosporin 0.8 
Clonostachydiol 0.4 
CNM 115443 0.4 
Cochliodinol n.a. 
Cochlioquinone A n.a. 
Communsein B 0.2 
Cordycepin 1 
Culmorin  4 
Curvularin  0.4 
Curvulin 0.12 
Cycloaspeptide A 3.2 
Cycloechinulin  0.12 
Cycloheximide  1 
Cyclo (L-Leu-L-Pro) 0.32 
Cyclo (L-Pro-L-Tyr) 0.4 
Cyclo (L-Pro-L-Val) 0.32 
Cyclopenin  0.08 
Cyclopenol 0.8 
Cyclopeptine 0.2 
Cyclopiazonic acid  6 
Cyclosporin A 2 
Cyclosporin B 2 
Cyclosporin C 2 
Cyclosporin D 0.2 
Cyclosporin H 0.4 
Cylindrol B 0.012 
Cylindrocarpon A 0.008 
Cytochalasin D 0.4 
Cytochalasin E 1.2 
Cytochalasin H 8 
Cytochalasin J 0.4 
Daunorubicin 6 
Deacetylneosolaniol 6 
Decalonectrin  2.8 
Decarestrictin  8 
Dechlorogriseofulvin  0.6 
Dechloroisochromophilon IV 0.6 
Deepoxy-deoxynivalenol 1 
Dehydroaustinol 1 
Dehydrocurvularin 0.8 
Dehydrocyclopeptine 0.8 
Dehydrogriseofulvin 0.2 
Demethylasteltoxin 3.2 
Demethylsulochrin 0.32 
Deoxyaltersolanio l A n.a. 
Deoxybrevianamid E 4 
Deoxyfusapyrone 0.4 
Deoxynivalenol 0.6 
Deoxynivalenol-3-Glucoside 0.4 
DON-Glutathion n.a. 
Deoxynivalenol-3-Sulfate  n.a. 
Deoxynivalenol-15-Sulfate n.a. 
Deoxypentahydroxyscirpenol n.a. 
  
Deoxytryptoquialanine n.a. 
Deoxytryptoquivaline A 1 
Desoxypaxillin  n.a. 
Desoxyverrucosidin n.a. 
Destruxin A  0.2 
Destruxin B 0.4 
Destruxin CHL 3.2 
Destruxin D 0.4 
Destruxin Ed  4 
Dethiosecoemestrin n.a. 
Diacetoxyscirpenol 0.2 
Dich lormethylasterric acid  0.4 
Dechloronornidulin 0.032 
Dihydrobotrydial n.a. 
Dihydrochlamydocin 0.28 
Dihydrocitrinone 1 
Dihydroergosine 0.08 
Dihydroergotamine 0.32 
Dihydrogriseofulvin  n.a. 
Dihydroinfectopyron 1.6 
Dihydrolysergol 0.2 
Dihydrosterigmatocystin n.a. 
Dihydrotrichotetronine 4 
Dihydroxycalonectrin  n.a. 
Dihydroxymellein  1 
Dimethoxymethylgrisantrion n.a. 
Dihydroxy-ZON-Mrethylether n.a. 
Dinactin  n.a. 
Dip lodiatoxin  4 
Doxorubicin 2 
Doxycyclin n.a. 
Drimane 6 12 
Drimane 8 0.8 
Elymoclavine  0.2 
Elymoclavine-Fructoside 0.6 
Emindole SA n.a. 
Emodin 0.028 
Enniat in A 0.008 
Enniat in A1 0.016 
Enniat in B 0.012 
Enniat in B1 0.02 
Enniat in B2 0.02 
Enniat in B3 0.0016 
epi-Equisetin 0.12 
Epoxyagroclavin  n.a. 
Epoxycytochalasin C 0.4 
Epoxycytochalasin D 0.4 
Equisetin 0.12 
Eremofort ine A 2 
Eremofort ine B 20 
Ergine 0.04 
Ergocornine 0.32 
Ergocorninine 0.08 
Ergocristam n.a. 
Ergocristinam n.a. 
Ergocristine 0.6 
Ergocristinine  0.08 
Ergocryptine 0.32 
  
Ergocryptinine 0.2 
Ergometrine  0.6 
Ergometrinine  0.04 
Ergosinine 0.12 
Ergosine 0.4 
Ergotaminine  0.08 
Ergotamine 0.32 
Ergovaline  n.a. 
Erythromycin  n.a. 
F01 1358-A  0.4 
Fallacinol 0.1 
Fellutannine A 0.32 
Fellutannine B 1.6 
Festuclavine 0.4 
FK 506 1 
FK 9775 A  n.a. 
FK 9775 B n.a. 
Flavipucin  0.2 
Flavoglaucin  0.12 
Fonsecin n.a. 
FS4 n.a. 
Fulvic acid  3 
Fumagillin  8 
Fumifungin 16 
Fumigaclav ine C 1.2 
Fumigaclav ine A 0.16 
Fumiquinazolin A 0.8 
Fumiquinazolin D 0.8 
Fumiquinazolin E n.a. 
Fumiquinazolin F 8 
Fumiquinazolin I n.a. 
Fumiquinazolin Derivat 8 
Fumitremorgin A  1 
Fumitremorgin B n.a. 
Fumitremorgin C 1 
Fumonisin A1 n.a. 
Fumonisin A1 precursor 1 
Fumonisin A2 n.a. 
Fumonisin B1 1.6 
Fumonisin B2 1.2 
Fumonisin B3 1.2 
Fumonisin B4 n.a. 
Fumonisin B6 n.a. 
Fusaproliferin  20 
Fusarenon-X 1.6 
Fusapyrone 0.4 
Fusaric acid  8 
Fusarin C 2.4 
Fusarinolic acid  n.a. 
Fusarielin A 20 
Fusidic acid  0 
Geldanamycin  0.16 
Geodin 2 
Geodin hydrate 4 
Gibberellic acid  8 
Gibepyron D 6 
Glioclad ic acid  3.2 
Gliotoxin  4 
  
Glyantrypine 0.32 
Gregatin B n.a. 
Griseofulvin 0.6 
Griseophenone B 1 
Griseophenone C 0.12 
Harzianopyridone 0.28 
Harzianum A 2 
HC-Toxin  0.4 
Helvolic acid 3.2 
Helvolinic acid  n.a. 
Heptaibin  10 
Heptelid ic acid  1.2 
Herquline A 0.08 
HT-2 Glucoside 0.8 
HT-2 Toxin  1.6 
hydrolysed Fumonisin B1 0.8 
hydrolysed Nidulin 0 
Hydroxycarnequinazoline A 0.6 
Hydroxycurvularin 0.6 
Hydroxyroquefortine C n.a. 
Hydroxysydonic acid 0.8 
Hypothemycin 2 
Ilicico lin A  0.08 
Ilicico lin B 0.16 
Ilicico lin C 0.32 
Ilicico lin E 0.08 
Infectopyron 4 
Infectopyron-Derivat 8 
Integracin A 0.04 
Integracin B 0.04 
Ionomycin  1.6 
Irgasan 40 
Isochromophilon III 10 
Isochromophilon IV 0.32 
Isochromophilon VI 0.6 
Isochromophilon IX 0.6 
Isofusidienol 1 
Isokotanin B 0.8 
Isorhodoptilometrin  0.032 
Josamycin n.a. 
K252a 1.6 
K252b 8 
K-76 Derivative 4 0.32 
Kipuksain B 1 
Kipuksain D 3.2 
KO 143 8 
Kojic acid 8 
Koninginin D 12 
Koninginin E 1 
Linamarin  1.2 
Lincomycin n.a. 
LL-Z 1272e 0.032 
Lolitrem B n.a. 
Lo litrem N n.a. 
Lotaustralin 0.16 
Luteoskyrin n.a. 
Luteusin A 1 
Lysergol 0.4 
  
Macrosphaelide A 0.12 
Macrosporin 0.02 
Malformin A  0.4 
Malformin A2 0.4 
Malformin C 0.08 
Marcfortine A  0.08 
Marcfortine B n.a. 
Marcfortine C n.a. 
Meleagrin  3 
Meleagrin Derivat 1.2 
Methoxycurvularin  1 
Methoxysterigmatocystin 0.4 
Methylasterric acid 0.08 
Methylsulochrin 0.12 
Methysergid 0.2 
Mevastatin 1.2 
Mevinolin  0.4 
Mithramycin C n.a. 
Mitomycin n.a. 
Monactin 0.12 
Moniliformin  0.8 
Monocerin 0.2 
Monomethylcurvulin 1.2 
Mycophenolic acid  0.12 
Mycophenolic acid IV 0.4 
Myriocin  1.6 
N-Benzoyl-Phenylalanin  0.4 
Neoechinulin A  0.32 
Neosolaniol 0.8 
Neoxaline  0.2 
NG 012 0.6 
Nidulin  0.12 
Nidurufin  0.08 
Nigericin 0.08 
NIgragillin n.a. 
Nivalenol 0.6 
Nivalenol-Glucosid 1.6 
Nonactin 0.012 
Norlichexanthone 0.12 
Nornidulin  0.04 
Norsolorin ic acid  0.4 
Nortryptoquialanine n.a. 
Notoamide E 0.4 
Notoamide Derivat  0.4 
NP 19199 3.2 
NP 12318 0.4 
NT-2 Toxin  3.2 
NX-1 n.a. 
NX-2 n.a. 
NX-3 n.a. 
Ochratoxin A  0.2 
Ochratoxin alpha 4 
Ochratoxin B 0.8 
Ochratoxin C 0.12 
Ochrephilone  0.2 
Okaramine D 0.32 
Oligomycin A  4 
Oligomycin B 2.4 
  
O-Methylsterigmatocystin 0.12 
Oosporin 0 
Ophiobolin A  0.8 
Ophiobolin B 3.4 
Orsellin ic acid  20 
oxidized Elymoclav in 1 
oxidized Luol 4 
Oxalicine  3 
Oxaline 0.2 
Oxaspirodion  40 
Oxytetracyclin n.a. 
Papyracillic acid 2.8 
Paracelsin A  n.a. 
Paracelsin B n.a. 
Paraherquamide A  0.4 
Paraherquamide E 0.2 
Paspalic acid  200 
Paspalin n.a. 
Paspalinin  n.a. 
Paspalitrem A  n.a. 
Paspalitrem B n.a. 
Patulin  2.4 
Paxillin  4 
Penicillazaphilone B 0.3 
Penicillic  acid  2 
Penicillide  0.48 
Penicillin G 0.2 
Penicillin V n.a. 
Penigequinolone A 0.12 
Penitrem A  0.4 
Pennigritrem A  20 
Pentahydroxyscirpenol 4 
Pentoxyfy lline  0.08 
Pestalotin 0.2 
Phenopyrrozin  1.2 
Phomalactone 0.4 
Phomalone 0.12 
Phomopsin A 0.4 
Phomopsin B n.a. 
Phomopsolide B 0.4 
Physcion 3.2 
Piscarin in A 1 
Porritoxinol 3.2 
Prehelminthosporol n.a. 
Prehelminthosporollacton n.a. 
Prelaptin  0.08 
PR Toxin  n.a. 
Pseurotin A 4 
Pseurotin D n.a. 
Puromycin  0.4 
Purpactin A 0.4 
Purpuride  0.12 
Pyranonigrin  28 
Pyrenophorol 1.2 
Pyrenocin A 1.2 
Pyripyropene A 2.8 
Pyripyropene B n.a. 
Pyripyropene D 0.4 
  
Pyrophen 0.4 
Quadrone 2 
Questiomycin A  0.8 
Quinadoline A  1 
Quinadoline B 4 
Quinolactacin A  0.04 
Quinocitrinine A  0.04 
Radicicol 0.6 
Radiclonic acid 1 
Rapamycin  12 
Rasfonin 3.2 
Roquefortine C 1 
Roquefortine D 0.4 
Roquefortine E 0.2 
Roridin A  0.6 
Roridin L-2 n.a. 
Rubellin D 0.28 
Rubratoxin A  n.a. 
Rubrofusarin 2 
Rugulosin 0.2 
Rugulosuvine 0.12 
Rugulotrosin 12 
Rugulovasine A 0.28 
Sambucinol 8 
Satratoxin F n.a. 
Satratoxin G n.a. 
Satratoxin H n.a. 
Scalusamid A 0.6 
Sclerotio ramin 1.2 
Sclerotio rin  1 
Sch 725680 n.a. 
Secalonic acid D 4 
Secoemestrin C Derivat 10 
Seco-Sterigmatocystin 0.12 
semi Vioxanthin  0.8 
semi Xanthomegnin  n.a. 
Siccanin  0.2 
Siccanol n.a. 
Setusosin 1.2 
Skyrin  0.2 
S-Methyl-deoxynivalenol n.a. 
Sorbicillactone 400 
Sphingofungin B 32 
Sphingofungin D 0.32 
Spiramycin  n.a. 
Spirodihydrobenzofuranlactam IV 0.8 
Sporogen AO I 4 
Stachybotramide 2 
Stachybotrylactam 0.4 
Staurosporin 4 
Stemphylpery lenol 16 
Sterigmatocystin 0.16 
Sulochrin  0.6 
Sydonic acid 0.4 
Sydowinin A  1 
Synazerol n.a. 
T2-Glucoside n.a. 
T2-Tetrao l 1.4 
  
T2-Toxin  0.4 
T2-Triol 6 
Taxol n.a. 
Tenellin 12 
Tensidol B n.a. 
Tentoxin  0.04 
Tenuazonic acid  4 
Ternatin 0.2 
Terpendole C n.a. 
Terpendole E n.a. 
Terphenyllin  0.6 
Terrecyclic acid 20 
Terrein 4 
Terretonin 3.2 
Terretonin F Derivat 0.6 
Territrem B 1.2 
Tetracycline  2 
Tetrahydrobostrycin 0.32 
Thielavin B 0.2 
Thiolutin  0.6 
TR-2 Toxin n.a. 
TriacetoxyDON 0.6 
Trichalasin B 1 
Trichodermamide C 0.32 
Trichodermin 2 
Trichodimerol 1 
Trichostatin A 0.8 
Trichothecolone n.a. 
Trichothecin n.a. 
Trypacidin  n.a. 
Tryprostatin A 0.6 
Tryprostatin B n.a. 
Tryptophol 4 
Tryptoquialanine n.a. 
Tryptoquialanine-Derivat 0.12 
Tryptoquialanone 0 
Tryptoquivaline A 0.4 
Tryptoquivaline F 3.2 
Tryptoquivaline G 0.32 
Tylosin n.a. 
Unguinol 0.08 
Unugisin E 0.6 
Usnic acid  0.016 
Ustiloxin A  n.a. 
Ustiloxin B n.a. 
Ustiloxin D n.a. 
Ustusol A 0.32 
Valinomycin  2 
Vancomycin  n.a. 
Vermistatin 0.1 
Verrucarin A  n.a. 
Verrucarin J n.a. 
Verrucaro l n.a. 
Verrucofort ine 0.012 
Verrucosidin  n.a. 
Verruculogen 20 
Verruculotoxin 0.12 
Versicolorin A  0.12 
  
Versicolorin C 0.12 
Verticillin A  10 
Vio laceic acid  0.6 
Vio laceol I 4 
Vio laceol II 4 
Viomellein  80 
Vioxanthin n.a. 
Virid icatin  0.6 
Virid icatol 1.2 
Virid icatum toxin 8 
Virido l 0.8 
WIN 64821 0.4 
WIN 68577 4 
Wortmannin 2 
Xanthocillin  4 
Xanthomegnin 4 
Xanthotoxin  0.16 
Yaequinolone J2 n.a. 
Zaragozic acid A  n.a. 
Zearalenone 0.06 
Zearalenone-16-Glucoside n.a. 
Zearalenone-4-Glucoside  n.a. 
Zinndiol 0.32 
Zinniamide 0.4 
Zinniol 6 
 
 
 
